First Patient Treated in Cutting-Edge Rare Liver Disease Clinical Trial
July 20, 2024
July 20, 2024
BIRMINGHAM, England, July 20 (TNSres) -- The University of Birmingham issued the following news:
* * *
The study will explore the potential of faecal microbiota transplantation to slow the progression of primary sclerosing cholangitis
* * *
The first patient has been recruited to the FARGO clinical trial, which is testing a new treatment to improve quality of life for patients living with primary sclerosing cholangitis (PSC), a rare liver disea . . .
* * *
The study will explore the potential of faecal microbiota transplantation to slow the progression of primary sclerosing cholangitis
* * *
The first patient has been recruited to the FARGO clinical trial, which is testing a new treatment to improve quality of life for patients living with primary sclerosing cholangitis (PSC), a rare liver disea . . .